Canine Masticatory Muscle Myositis: Welfare and Treatment

Masticatory muscle myositis (MMM) is an immune-mediated inflammatory disease affecting the jaw muscles of dogs, causing pain, inability to open the mouth, and severe welfare impacts if untreated.

Key Facts

MMM is caused by an autoimmune attack on type 2M muscle fibres unique to the jaw muscles
Golden retrievers, Dobermanns, and Cavalier King Charles Spaniels are predisposed breeds
Acute phase presents with painful jaw swelling; chronic phase causes fibrosis and restricted mouth opening
Diagnosis uses a specific blood test for 2M antibody titres
Immunosuppressive doses of corticosteroids are the primary treatment

Welfare Considerations

Masticatory muscle myositis causes severe acute pain in affected dogs, who are unable to eat, drink, or pant normally during flare episodes. If untreated or under-treated, the chronic fibrotic phase results in permanent inability to open the mouth, requiring permanent dietary modification and causing lasting welfare compromise. Early aggressive immunosuppressive treatment is essential to prevent irreversible fibrosis and restore normal jaw function. Regular monitoring of 2M antibody titres guides treatment decisions and reduces relapse risk.

What You Can Do

Seek urgent veterinary assessment if your dog has a painful, swollen jaw or cannot open its mouth
Request 2M antibody testing specifically if MMM is suspected
Follow complete corticosteroid treatment courses to prevent fibrotic complications
Provide softened or liquid food during treatment to maintain nutrition
Maintain long-term monitoring through antibody titre testing to detect subclinical relapse